Mathieu Peyrou graduated from the Ecole Nationale Veterinaire de Toulouse (ENVT) in 1999. After an internship at the Veterinary Faculty in St-Hyacinthe, QC, Canada, he undertook a MSc in Veterinary Pharmacology at the University of Montreal, followed by a PhD in Pharmacology and Toxicology at the Atlantic Veterinary College in Canada. Mathieu is a Diplomate of the European College of Veterinary Pharmacology and Toxicology and Diplomate of the American College of Veterinary Clinical Pharmacology.

Mathieu has worked for more than 10 years in the veterinary pharmaceuticals industry with various R&D roles of increasing responsibilities. He joined Ceva in 2017 as Director of PreDevelopment and Preclinical Development. Since early 2019, Mathieu is Director of Clinical and Preclinical Development.